Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi In June, France hosted the launch of African Vaccine Manufacturing Accelerator (AVMA), an approximately US$1 billion project geared towards making vaccines more available in Africa –...

A new drug that can treat human African trypanosomiasis—commonly known as sleeping sickness—with just one dose has shown promise in a clinical trial in the Democratic Republic of the Congo and Guinea. www.science.org/content/article/news-at-a-glance-snags-emissions-monitoring-negotiations-biodiversity-sleeping-sickness? The rare disease is caused by the...